Literature DB >> 10220608

Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Comparative economic data regarding lipid-lowering drugs.

J S Schwartz1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10220608     DOI： 10.1016/s0002-8703(99)70440-0

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  3 in total

1.  Effects of internet-based tailored advice on the use of cholesterol-lowering interventions: a randomized controlled trial.

Authors:  Ruth Webster; Stephen Ch Li; David R Sullivan; Kathy Jayne; Steve Ys Su; Bruce Neal
Journal:  J Med Internet Res       Date:  2010-09-13       Impact factor: 5.428

Review 2.  [Recommendations for statin therapy in the elderly].

Authors:  S Döser; W März; M-F Reinecke; P Ringleb; A Schultz; P Schwandt; H J Becker; G Bönner; M Buerke; H C Diener; H Gohlke; U Keil; E B Ringelstein; A Steinmetz; R Gladisch; M Wehling
Journal:  Internist (Berl)       Date:  2004-08-03       Impact factor: 0.743

Review 3.  Benefits of lipid-lowering agents in stroke and coronary heart disease: pharmacoeconomics.

Authors:  S G Rockson
Journal:  Curr Atheroscler Rep       Date:  2000-03       Impact factor: 5.967
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.